☆ 4.7 Article

A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer

FRONTIERS IN ENDOCRINOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Radiology, Nuclear Medicine & Medical Imaging

Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer

Yanbo Li et al.

Summary: A nomogram based on pretreatment DCE-MRI was developed to predict pCR after NAC in TNBC patients. Tumor volume on DCE-MRI, TTP, and AR status were identified as independent predictors of pCR. The nomogram showed good predictive performance in both the primary and validation cohorts.

EUROPEAN RADIOLOGY (2022)

添加到收藏夹

Article Oncology

Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes

Cheng Yan et al.

Summary: Using a total of 222 autophagy-related genes, a survival model based on six genes (CDKN1A, CTSD, CTSL, EIF4EBP1, TMEM74, and VAMP3) was established to predict the prognosis of TNBC patients. The model was validated using independent cohorts and demonstrated accuracy in survival prediction. The study also identified EIF4EBP1 as a potential driver of proliferation and migration in TNBC cell lines, suggesting new therapeutic targets for the disease.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence

Nahlah Makki Almansour

Summary: This article provides up-to-date information on triple-negative breast cancer (TNBC), including epidemiology, risk factors, metastasis, signaling pathways, immune suppressive cells, current therapies, prognosis, and the role of artificial intelligence in diagnosis. The information presented may be helpful for researchers to advance the understanding of TNBC and provide suitable disease management.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

添加到收藏夹

Article Oncology

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis

Yinggang Xu et al.

Summary: A nomogram was constructed to predict the overall survival (OS) of triple-negative apocrine carcinoma (TNAC) patients. The nomogram showed good discrimination and clinical utility in evaluating patient prognosis and guiding treatment decisions.

BREAST (2022)

添加到收藏夹

Review Oncology

A clinical calculator to predict disease outcomes in women with triple-negative breast cancer

Mei-Yin C. Polley et al.

Summary: Clinical calculators for predicting recurrence-free survival and overall survival in triple-negative breast cancer patients were constructed and validated, with higher accuracy and predictive ability than base models.

BREAST CANCER RESEARCH AND TREATMENT (2021)

添加到收藏夹

Review Oncology

Precision medicine in breast cancer: From clinical trials to clinical practice

Edoardo Crimini et al.

Summary: This review presents the most important molecular targets in breast cancer, classified according to their pathway and in accordance with ESCAT, assisting clinicians in making therapeutic decisions.

CANCER TREATMENT REVIEWS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer

Peng Su et al.

Summary: This study identified five hub prognostic genes associated with macrophages and established a prognostic model to predict the survival of TNBC patients. Additionally, these five genes were found to be related to gemcitabine resistance in TNBC patients.

PEERJ (2021)

添加到收藏夹

Article Oncology

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

Meizhen Zhu et al.

Summary: Neoadjuvant chemotherapy is important for locally advanced TNBC. Predicting disease-free survival is crucial. Factors such as response to treatment, residual tumor size, and lymphatic vessel invasion can impact prognosis. The constructed nomogram showed superior predictive performance for TNBC patients compared to current staging systems.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Emerging Therapeutics for Patients with Triple-Negative Breast Cancer

Elisa Agostinetto et al.

Summary: Triple negative breast cancer (TNBC) accounts for approximately 10-15% of all breast cancers and is associated with a poor prognosis. Recent emerging therapies such as new post-neoadjuvant chemotherapy strategies, PARP inhibitors, immune checkpoint inhibitors, and combination therapies are showing promise in improving patient outcomes for TNBC. The treatment landscape for TNBC is evolving towards a more personalized approach with the expectation of better outcomes.

CURRENT ONCOLOGY REPORTS (2021)

添加到收藏夹

Article Oncology

Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance

Jingbo Wang et al.

Summary: The study investigated conditional survival and dynamic failure hazard in non-metastatic nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Results showed that survival prospects improve over years with distinct patterns across stages, highlighting the importance of personalized decision-making in clinical management and surveillance counseling.

CANCER MEDICINE (2021)

添加到收藏夹

Article Cell Biology

A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer

Xia Yang et al.

Aging-US (2021)

添加到收藏夹

Article Surgery

Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database

Lingyu Han et al.

Summary: The study found that patients with metastatic colorectal cancer demonstrated a substantial increase in conditional survival over time. Factors affecting survival may change gradually, and nomograms based on survival time can accurately predict survival for patients with mCRC.

INTERNATIONAL JOURNAL OF SURGERY (2021)

添加到收藏夹

Article Oncology

Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma

Reyizha Nuersulitan et al.

Summary: The study demonstrates that the survival probability of patients with classical Hodgkin's lymphoma increases over time while the hazard of failure decreases gradually. Early-stage patients have lower failure hazard rates, and advanced-stage patients also experienced significant decreases in failure hazard rates after 3 years.

CANCER MANAGEMENT AND RESEARCH (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study

Xiaozhu Liu et al.

Summary: This study utilized the SEER database to evaluate the prognostic value of clinical characteristics in elderly patients with TNBC, constructing a nomogram to predict 1-, 3-, and 5-year prognoses. Results showed that age, race, grade, chemotherapy and radiotherapy status, TN stage, and tumor size were independent factors influencing prognosis. The nomogram was validated with C-index, calibration curve, and DCA, demonstrating its clinical applicability in guiding patient risk stratification and treatment decisions.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Oncology

Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model

Anouk E. J. Latenstein et al.

ANNALS OF SURGICAL ONCOLOGY (2020)

添加到收藏夹

Article Surgery

Conditional survival after neodjuvant chemotherapy and surgery for oesophageal cancer

E. R. C. Hagens et al.

BRITISH JOURNAL OF SURGERY (2020)

添加到收藏夹

Article Pathology

CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer

Bruna Cerbelli et al.

VIRCHOWS ARCHIV (2020)

添加到收藏夹

Review Environmental Sciences

Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

Mauricio A. Medina et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

添加到收藏夹

Article Oncology

Conditional survival analysis of hepatocellular carcinoma

Mihir M. Shah et al.

JOURNAL OF SURGICAL ONCOLOGY (2020)

添加到收藏夹

Review Oncology

Triple-negative breast cancer therapy: Current and future perspectives (Review)

Kwang-Ai Won et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer

Xiang Cui et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Review Oncology

Triple-negative breast cancer molecular subtyping and treatment progress

Li Yin et al.

BREAST CANCER RESEARCH (2020)

添加到收藏夹

Article Oncology

Outcomes for Patients with Non-metastatic Triple-negative Breast Cancer in New Zealand

M. James et al.

CLINICAL ONCOLOGY (2019)

添加到收藏夹

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State

Betsy A. Kohler et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

添加到收藏夹

Article Oncology

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State

Betsy A. Kohler et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

添加到收藏夹

Article Oncology

Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer

Johan L. Dikken et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

添加到收藏夹

Editorial Material Oncology

Dynamic Prognostication Using Conditional Survival Estimates

Emily C. Zabor et al.

CANCER (2013)

添加到收藏夹

Article Oncology

Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07

Beth A. Zamboni et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.